Blogs about: Vasogen
Featured Blog
Monday Biotech Deal Review: October 25, 2009
A very busy deal week coincided with a very busy work week (for those of us with day jobs), so allow me a particularly grateful thank-you to Jacob Cawker, who’s been an invaluable help with the … more →
The Cross-Border Biotech Blog
Monday Biotech Deal Review: October 25, 2009
— 2 comments
Jeremy G wrote 2 months ago: A very busy deal week coincided with a very busy work week (for those of us with day jobs), so allow … more →
Monday Deal Review: August 24, 2009
— 1 comment
Jeremy G wrote 4 months ago: This week saw a few headline deals that we covered at the time, including the Vasogen-Cervus-Intelli … more →
Another Biotech Windfall from the SIFT Tax: Vasogen Molts for Cervus and Merges with IntelliPharmaCeutics. Shareholders Applaud.
— 3 comments
Jeremy G wrote 4 months ago: In July, we covered the deal ConjuChem Biotechnologies Inc. (TSX: CJB) made with Colabor Income Fund … more →
Monday Deal Review: February 9, 2009
— 3 comments
Jeremy G wrote 10 months ago: Vasogen Inc. (NASDAQ:VSGN; TSX:VAS) sold a patent application for US$400,000, but reserved rights fo … more →
Vasogen's Heart Stops
warrenh wrote 1 year ago: Mississauga, Ontario – Rumours that Toronto-based Vasogen Incorporated’s new Celacade tr … more →
